Battaglia Marissa R, Alemzadeh Ramin, Katte Heidi, Hall Pamela L, Perlmuter Lawrence C
Rosalind Franklin University of Medicine and Science, North Chicago, Illinois 60064, USA.
J Pediatr Psychol. 2006 Jul;31(6):552-6. doi: 10.1093/jpepsy/jsj047. Epub 2005 Jul 13.
To evaluate whether insulin pump therapy [continuous subcutaneous insulin infusion (CSII)] is associated with a lower frequency of disordered eating, better glycemic control, and improved quality of life and self-efficacy compared to multiple daily injections (MDI) in adolescent females with type 1 diabetes mellitus (T1DM).
This cross-sectional study included 22 adolescent females using CSII and 47 adolescent females using MDI who completed standardized questionnaires measuring disordered eating, quality of life, and self-efficacy. Most recent glycosylated hemoglobin (HbA1(c)) and measures of personal characteristics were drawn from medical records.
The CSII group exhibited better glycemic control and reported higher quality of life and more self-efficacy. However, the groups did not differ significantly on disordered eating behaviors and attitudes.
Insulin pump therapy may provide a means for improving glycemic control, quality of life, and self-efficacy in adolescent females with type 1 diabetes.
评估与多次皮下注射(MDI)相比,胰岛素泵治疗[持续皮下胰岛素输注(CSII)]是否能降低1型糖尿病(T1DM)青春期女性饮食失调的频率,改善血糖控制、生活质量和自我效能感。
这项横断面研究纳入了22名使用CSII的青春期女性和47名使用MDI的青春期女性,她们完成了测量饮食失调、生活质量和自我效能感的标准化问卷。最新糖化血红蛋白(HbA1(c))和个人特征指标来自病历。
CSII组血糖控制更好,生活质量更高,自我效能感更强。然而,两组在饮食失调行为和态度方面没有显著差异。
胰岛素泵治疗可能为改善1型糖尿病青春期女性的血糖控制、生活质量和自我效能感提供一种方法。